ASMB
Price:
$16.99
Market Cap:
$107.81M
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection...[Read more]
Industry
Biotechnology
IPO Date
2010-12-17
Stock Exchange
NASDAQ
Ticker
ASMB
According to Assembly Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 90.35M. This represents a change of 114.27% compared to the average of 42.17M of the last 4 quarters.
The mean historical Enterprise Value of Assembly Biosciences, Inc. over the last ten years is 2.10B. The current 90.35M Enterprise Value has changed 330.70% with respect to the historical average. Over the past ten years (40 quarters), ASMB's Enterprise Value was at its highest in in the March 2018 quarter at 11.86B. The Enterprise Value was at its lowest in in the March 2023 quarter at 1.99M.
Average
2.10B
Median
566.92M
Minimum
13.98M
Maximum
9.56B
Discovering the peaks and valleys of Assembly Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 284.87%
Maximum Annual Enterprise Value = 9.56B
Minimum Annual Increase = -91.82%
Minimum Annual Enterprise Value = 13.98M
Year | Enterprise Value | Change |
---|---|---|
2023 | 27.54M | 97.03% |
2022 | 13.98M | -77.34% |
2021 | 61.69M | -62.62% |
2020 | 165.02M | -67.18% |
2019 | 502.79M | -91.82% |
2018 | 6.15B | -35.67% |
2017 | 9.56B | 284.87% |
2016 | 2.48B | 78.89% |
2015 | 1.39B | 119.96% |
2014 | 631.04M | -26.79% |
The current Enterprise Value of Assembly Biosciences, Inc. (ASMB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
34.40M
5-year avg
154.20M
10-year avg
2.10B
Assembly Biosciences, Inc.’s Enterprise Value is greater than Spero Therapeutics, Inc. (12.49M), greater than Achilles Therapeutics plc (-61068820.00), less than Instil Bio, Inc. (171.51M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than CytomX Therapeutics, Inc. (62.24M), less than Nuvation Bio Inc. (947.94M), greater than NextCure, Inc. (25.04M),
Company | Enterprise Value | Market cap |
---|---|---|
12.49M | $71.07M | |
-61068820.00 | $29.58M | |
171.51M | $92.68M | |
-6333315.00 | $8.20M | |
62.24M | $93.74M | |
947.94M | $692.60M | |
25.04M | $39.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assembly Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assembly Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Assembly Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
What is the 3-year average Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
What is the 5-year average Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
How does the current Enterprise Value for Assembly Biosciences, Inc. (ASMB) compare to its historical average?